Aspira Pathlab & Diagnostics Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Aspira Pathlab & Diagnostics Quarterly Results    (APDL)

Here are the latest quarterly results of Aspira Pathlab & Diagnostics . For more details, see the Aspira Pathlab & Diagnostics financial fact sheet and Aspira Pathlab & Diagnostics share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Aspira Pathlab & Diagnostics Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
3
Jun-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m2322201554424159 
Other income Rs m11111100 
Turnover Rs m2423201654434159 
Expenses Rs m2626271635343135 
Gross profit Rs m-3-4-7-11981024 
Depreciation Rs m44444444 
Interest Rs m23222221 
Profit before tax Rs m-9-10-13-6133420 
Tax Rs m00000000 
Profit after tax Rs m-9-10-13-6133420 
Gross profit margin %-12.3-17.3-36.7-6.434.718.523.741.3 
Effective tax rate %0.00.00.00.00.00.00.00.0 
Net profit margin %-37.0-45.9-66.8-41.424.76.110.434.0 
Diluted EPS Rs -0.8 -1.0 -1.3 -0.6 1.3 0.2 0.4 1.9  
Diluted EPS (TTM) Rs NA -4.1 -4.1 -3.7 -1.6 -0.3 1.3 3.9  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

More Hospital & Healthcare Services Company Quarterly Results:   ISTREET NETWORK  GODAVARI DRU  BALAXI PHARMA  LINCOLN PHAR  GLAND PHARMA  

Compare ASPIRA PATHLAB & DIAGNOSTICS With:   ISTREET NETWORK  GODAVARI DRU  BALAXI PHARMA  LINCOLN PHAR  GLAND PHARMA  



Today's Market

Sensex Trades Marginally Lower, Dow Futures Down by 440 Points(12:30 pm)

Share markets in India are presently trading marginally lower. The BSE Sensex is trading down by 57 points, down 0.1%, at 58,958 levels.

Views on news

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

Cipla Shares Tank Despite Strong Earnings (Views On News)

Aug 6, 2021

The stock fell 3.5% even as the company reported numbers higher than analysts' expectations.

Glenmark Life Sciences Makes Lacklustre Debut. Shares List At 4% Premium (Views On News)

Aug 6, 2021

Glenmark Life Sciences' IPO had received strong response from investors as the offer was subscribed 44.17 times.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider (Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore (Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

5 Indian Companies that are Leading the AI Race (Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

The Top Stocks to Sell in this Bull Market (Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Specialty Chemical Stocks that Turned Multibaggers in One Year (Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ASPIRA PATHLAB & DIAGNOSTICS SHARE PRICE


Sep 20, 2021 03:36 PM

TRACK ASPIRA PATHLAB & DIAGNOSTICS

  • Track your investment in ASPIRA PATHLAB & DIAGNOSTICS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASPIRA PATHLAB & DIAGNOSTICS

ASPIRA PATHLAB & DIAGNOSTICS - ASTER DM HEALTHCARE COMPARISON

COMPARE ASPIRA PATHLAB & DIAGNOSTICS WITH

MARKET STATS